Cite
HARVARD Citation
Yi, B. et al. (2022). Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. Journal of thrombosis and haemostasis. pp. 307-315. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yi, B. et al. (2022). Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. Journal of thrombosis and haemostasis. pp. 307-315. [Online].